nach oben

Clinical Journal of Gastroenterology

Erschienen in:

01.08.2009 | Clinical Review

Venous thromboembolism in abdominal cancer surgery

verfasst von: Masato Sakon, Masataka Ikeda

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Venous thromboembolism (VTE) is recognized as a serious complication in both surgical and non-surgical patients. Cancer, particularly adenocarcinoma developing in the digestive organs, is one of the most potent risk factors for VTE, as first described by Trousseau in 1865. Cell membrane microparticles shedding from cancer cells play a critical role in venous clot formation through tissue factor (TF)-mediated activation of the coagulation system. Since recent prospective studies have demonstrated that VTE risk in Japanese surgical patients is comparable to that in Caucasians, perioperative thromboprophylaxis with anticoagulants is now considered essential in patients undergoing abdominal cancer surgery, in addition to mechanical thromboprophylaxis. Recent multi-center studies have also shown the efficacy and safety of enoxaparin, a low molecular weight heparin (LMWH), and fondaparinux, a synthetic Xa inhibitor, in VTE prevention after abdominal cancer surgery. Anticoagulants like LMWH are expected to exert not only thromboprophylactic but also antineoplastic effects.

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–64.PubMed

Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop Relat Res. 2000; (375):168–74.

Kobayashi T, Nakamura M, Sakuma M, Yamada N, Sakon M, Fujita S, et al. Incidence of pulmonary thromboembolism (PTE) and new guidelines for PTE prophylaxis in Japan. Clin Hemorheol Microcirc. 2006;35(1–2):257–9.PubMed

Sakon M, Kakkar AK, Ikeda M, Sekimoto M, Nakamori S, Yano M, et al. Current status of pulmonary embolism in general surgery in Japan. Surg Today. 2004;34:805–10.CrossRefPubMed

Trousseau A. Phlegmasia alba dolens. In: Trousseau A, editor. Clinique medicinale de lHotel-Dieu de Paris. Paris: Bailliere J.-B. et fils; 1865. p. 645–712.

Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124(3 Suppl):58S–68S.CrossRefPubMed

Gore I, Hirst AE, Tanaka K. Myocardial infarction and thromboembolism: a comparative study in Boston and Kyushu, Japan. Arch Intern Med. 1964;113:323–30.CrossRefPubMed

Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan. J Thromb Haemost. 2006;4:581–6.CrossRefPubMed

Nakamura M. Japanese guidelines for prevention of venous thromboembolism. J Jpn Soc Anesth. 2004;24:480–7.

10.

Seo N. Up-to-date medical care for perioperative venous thromboembolism in Japan—standardization of care for perioperative venous thromboembolism in Japan: preface. Masui. 2007;56:758–9.PubMed

11.

Lowe GD. Virchow’s triad revisited: abnormal flow. Pathophysiol Haemost Thromb. 2003;33:455–7.CrossRefPubMed

12.

Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 Suppl):132S–75S.CrossRefPubMed

13.

Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001;20:1–37.CrossRefPubMed

14.

http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7207.

15.

Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119:60–8.CrossRefPubMed

16.

Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005;3:1590–6.CrossRefPubMed

17.

Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31:388–94.CrossRefPubMed

18.

Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18:600–8.CrossRefPubMed

19.

Kwon HC, Oh SY, Lee S, Kim SH, Han JY, Koh RY, et al. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol. 2008;38:2–7.CrossRefPubMed

20.

Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res. 2007;13:2870–5.CrossRefPubMed

21.

Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M. Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S) HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol. 2007;14:862–8.CrossRefPubMed

22.

Opatrny L, Warner MN. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia. Am J Hematol. 2004;76:240–4.CrossRefPubMed

23.

Sakon M. The effect of enoxaparin on postoperative venous thromboembolism in abdominal surgery. J Japan Surg Assoc. 2008;69:542. (abstract).CrossRef

24.

Sakon M, Tsukamoto T, Kobayashi T, Fujita S, Kawashima T, Monden M. Clinical evaluation of fondaparinux for prevention of venous thromboembolism after major abdominal surgery: a randomized open-label study of fondaparinux and intermittent pneumatic compression as a benchmark. J Clin Therap Med. 2008;24:679–89.

25.

Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8:381–8.CrossRefPubMed

26.

Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387–94.CrossRefPubMed

27.

Kakkar AK, Hedges RA, Williamson RCN, Kakkar VV. Perioperative heparin therapy inhibits late death from metastatic cancer. Int J Oncol. 1995;6:885–8.PubMed

28.

Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol. 2004;22:1944–8.CrossRefPubMed

29.

Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol. 2005;23:2130–5.CrossRefPubMed

30.

Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost. 2004;2:1266–71.CrossRefPubMed

31.

Lee AY, Rickles FR, Julian JA, Gent M, Baker RI, Bowden C, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23(10):2123–9.CrossRefPubMed

32.

Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost. 2007;5(Suppl 1):246–54.CrossRefPubMed

33.

Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-Habermann B, et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood. 2008;111:190–9.CrossRefPubMedPubMedCentral

34.

Bluff JE, Brown NJ, Reed MW, Staton CA. Tissue factor, angiogenesis and tumour progression. Breast Cancer Res. 2008;10:204.CrossRefPubMedPubMedCentral

Titel: Venous thromboembolism in abdominal cancer surgery
verfasst von: Masato Sakon
Masataka Ikeda
Publikationsdatum: 01.08.2009
Verlag: Springer Japan
Erschienen in: Clinical Journal of Gastroenterology / Ausgabe 4/2009
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI: https://doi.org/10.1007/s12328-009-0092-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

An ulcer negative for Helicobacter pylori and nonsteroidal anti-inflammatory drugs? Consider herbal treatment as the culprit!

A solitary fibrous tumor originating from the liver surface

A case of gastric adenocarcinoma arising from a fundic gland polyp

Differentiated adenocarcinoma with a gastric phenotype in the stomach: difficulties in clinical and pathological diagnoses

Large-cell neuroendocrine carcinoma of the distal bile duct